Instruction to Authors

E Journal of Cardiovascular Medicine is published quarterly (March, June, September, December). It aims to publish research articles and reviews of high quality which cover all aspects of surgery of the heart, vessels and the chest.

The abbreviation of the E Journal of Cardiovascular Medicine is EJCM.

E Journal of Cardiovascular Medicine does not charge any article submission, processing or publication charges.

The scientific and ethical liability of the manuscripts belongs to the authors and the copyright of the manuscripts belongs to the Heart and Health Foundation of Turkey. Authors are responsible for the contents of the manuscript and accuracy of the references. All manuscripts submitted for publication must be accompanied by the Copyright Transfer Form. Once this form, signed by all the authors, is submitted, it is understood that neither the manuscript nor the data it contains have been submitted elsewhere or previously published and authors declare the statement of scientific contributions and responsibilities of all authors. Abstracts presented at congresses are eligible for evaluation.

The Editorial Policies and General Guidelines for manuscript preparation specified below are based on “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals” (ICMJE Recommendations) by the International Committee of Medical Journal Editors.

Peer-Review

E Journal of Cardiovascular Medicine is an independent journal based on double-blind peer-review principles. The manuscript is assigned to the Editor-in-Chief, who reviews the manuscript and makes an initial decision based on manuscript quality and editorial priorities. Manuscripts that pass initial evaluation are sent to an Associate Editor. The Associate Editor assignes the manuscript to two reviewers (internal and/or external). The reviewers must review the manuscript within 21 days. The Associate Editor recommends a decision based on the reviewers’ recommendations and sends the manuscript to the Editor-in-Chief. The Editor-in-Chief makes a final decision based on editorial priorities, manuscript quality, and Associate Editor’s and reviewers’ recommendations. If there are any conflicting recommendations from reviewers, the Editor-in-Chief may assign a new reviewer.

All manuscripts submitted are screened for plagiarism using Crossref Similarity Check powered by “iThenticate” software. Results indicating plagiarism may cause manuscripts being returned or rejected.

Ethic

Experimental, clinical and drug studies requiring approval by an ethics committee must be submitted to the E Journal of Cardiovascular Medicine with an ethics committee approval report confirming that the study was conducted in accordance with international agreements and the Declaration of Helsinki. The approval of the ethics committee and the fact that informed consent was given by the patients should be indicated in the Materials and Methods section. In experimental animal studies, the authors should indicate that the procedures followed were in accordance with animal rights as per the Guide for the Care and Use of Laboratory Animals and they should obtain animal ethics committee approval.

Preparation of research articles, systematic reviews and meta-analyses must comply with study design guidelines:

CONSORT statement for randomized controlled trials

PRISMA statement of preferred reporting items for systematic reviews and meta-analyses

STARD checklist for the reporting of studies of diagnostic accuracy

STROBE statement, a checklist of items that should be included in reports of observational studies

MOOSE guidelines for meta-analysis and systemic reviews of observational studies

Authors must provide disclosure/acknowledgment of financial or material support, if any was received.

If the article includes any direct or indirect commercial links or if any institution provided material support to the study, authors must state in the cover letter that they have no relationship with the commercial product, drug, pharmaceutical company, etc. concerned; or specify the type of relationship (consultant, other agreements).

Authors must provide a statement on the absence of conflicts of interest among the authors and provide authorship contributions.

In case of any suspicion or claim regarding scientific shortcomings or ethical infringement, the Journal reserves the right to submit the manuscript to the supporting institutions or other authorities for investigation. The Journal accepts the responsibility of initiating action but does not undertake any responsibility for an actual investigation or any power of decision.

Guidelines

Manuscripts can only be submitted electronically through EJManager website (https://www.ejmanager.com/my/ejcm/) after creating an account.

Format: Manuscripts should be prepared using Microsoft Word; font type and font size should preferably be Arial or Times New Roman 11 points. The manuscript should be double-spaced and should include line and page numbers.

Abbreviations: Abbreviations should be defined at first mention and used consistently thereafter. Internationally accepted abbreviations should be used; refer to scientific writing guides as necessary.

Cover letter: A cover letter should be enclosed to all new manuscripts (to be filled in online), specifying the name of the journal and the type of paper, and including the following statements:

  • The manuscript should not be previously published in print or electronic form and is not under consideration by another publication.
  • All authors should contribute to the content of the article.
  • All authors should read and approve the submission of the manuscript to ICVTS.
  • Subject to acceptance, authors will sign an exclusive license to publish.
  • No ethical problem or conflict of interest should exist.

 

Manuscript Types

All submitted articles must be accompanied by following files:

Title Page: This page should include the title of the manuscript, name(s) of the authors and author information. The following descriptions should be stated in the given order:

  1. Title should be brief and descriptive (100 characters) – no abbreviations are allowed, even if well known.
  2. List all authors by full first name, initial of or full middle name and family name. Qualifications are not required. Ensure the author names correspond (in spelling and order of appearance) with the metadata of the system.
  3. Include the name of all institutions with the location (department, institution, city, country) to which the work should be attributed (in English). Use superscript numbers to connect authors and their department or institution
  4. Name, address, e-mail, phone and fax number of the corresponding author
  5. If the manuscript was (or will be) presented at a meeting, include the meeting name, venue, and the date on which it was (or will be) presented; also indicate if you have submitted an Abstract of this manuscript for the EACTS or ESTS annual meeting and whether it has been accepted (if known).
  6. The total number of words of the whole article (including title page, abstract, main text, legends, tables and references) must be specified on the title page.

Abstract: It should be a concise summary of the manuscript. Reference citations are not allowed. The abstract should be factual and free of abbreviations, except for SI units of measurement. It should be in English, with a minimum of 150 and maximum of 350 words.

For original articles, the structured abstract should include the following sub-headings:

Objectives: The aim of the study should be clearly stated.

Materials and Methods: The study and standard criteria used should be defined; it should also be indicated whether the study is randomized or not, whether it is retrospective or prospective, and the statistical methods applied should be indicated, if applicable.

Results: The detailed results of the study should be given and the statistical significance level should be indicated.

Conclusion: Should summarize the results of the study, the clinical applicability of the results should be defined, and the favorable and unfavorable aspects should be declared.

Keywords: A list of minimum 3, but no more than 6 keywords must follow the abstract. Keywords should be consistent with “Medical Subject Headings” (MESH).

Original Articles

Clinical research should comprise clinical observation, new techniques or laboratory studies. Original research articles should include title, structured abstract, keywords relevant to the content of the article, introduction, materials and methods, results, discussion, references, tables/figures and acknowledgement sections. The manuscript should be formatted in accordance with the above-mentioned guidelines and should not exceed 3000 words.

Introduction: Should state the purpose of the investigation and give a short review of pertinent literature.

Materials and Methods: Should be described in detail with appropriate information about patients or experimental animals. Use of abbreviations renders the text difficult to read; abbreviations should be limited to SI units of measurement and to those most commonly used, e.g. VSD, ASD, CABG (abbreviations should not be included in headings and extensions should be included at first mention).

Results: Results should be reported concisely and regarded as an important part of the manuscript. They should be presented either in tables and figures, and briefly commented on in the text, or in the text alone. Repetition of results should be avoided.

Discussion: The discussion is an interpretation of the results and their significance with reference to pertinent work by other authors. It should be clear and concise.

Acknowledgements: Acknowledgements and details of non-financial support must be included at the end of the text before the references. Personal acknowledgements should precede those of institutions or agencies.

References: The number of references should not exceed 40. Authors are responsible for the accuracy of the references. See References Section for details about the usage and formatting required.

Case Reports

Case reports should present cases which are rarely seen, new surgery techniques, feature novelty in diagnosis and treatment, and contribute to our current knowledge. The first page should include the title, an unstructured abstract not exceeding 250 words, and keywords. The main text should not exceed 1500 words and consist of introduction, case report, discussion and references not exceeding 20.

Review Articles

Review articles must provide critical analyses of contemporary evidence and provide directions of current or future research. Reviews articles analyze topics in depth, independently and objectively. The first page should include the title, an unstructured abstract and keywords. Source of all citations should be indicated and references amount should not exceed 100. The main text should not exceed 5000 words.

References

Authors are responsible for the accuracy and completeness of their refences and for correct in-text citation. All references should be in accordance with following rules:

In-text citations: References should be indicated as superscript in the parentheses after the full stop of the relevant sentence. If the author(s) of a reference is/are indicated at the beginning of the sentence, this citation should be written as superscript in the parentheses immediately after the author’s name.

References section: References should be numbered consecutively in the order in which they are first mentioned in the text. If there are more than 6 authors, first 3 authors must be listed followed by “et al”. The titles of journals should be abbreviated according to the style used in the Index Medicus. If a refence from another language than English will be used, English version of the title should be referenced.

Reference Format

Journal: Sawhney N, Anousheh R, Chen WC, Narayan S, Feld GK. Five-Year Outcomes After Segmental Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation. Am J Cardiol 2009; 104(3):366–72.

Book: Baue AE, Geha AS, Hammond GL, Laks H, Naunheim KS. Gleen’s thoracic and cardiovascular surgery. 1st ed. London: Appleton&Lange; 1991.

Book Chapter: Weinberg PM. Aortic arch anomalies. In: Allen HD, Clark EB, Gutgesell HP, Driscoll DJ (eds). Moss and Adams’ heart disease in ınfants, children, and adolescents. 1st ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 707-735.

Conference Paper: Davis L, Lee M, Sheridan B, et al. Berlin Heart EXCOR support in the first year of life. In: 32nd EACTS Annual Meeting; 18-20 October, 2018; Milan, Italy.

Figures and Tables

All visual materials (pictures, graphs and drawn figures) must be named as “Figure”. All figures and tables must be cited within the main text consecutively. Legends of all figures must be submitted as separate page of main document. Each figure must be submitted as separate file and in “.jpeg” format. All figures shoud be of the possible highest quality and at a minimum resolution of 300 dpi. All figures must be original. Figures previously published by other sources, must be submitted with a copy of written permission of the owner of figure. All permissions must be obtained by authors prior to submission. For figures involved human studies, written informed consent must be taken from patient or his/her parent and uploaded during submission. Otherwise, patient’s names must not be indicated and their eyes must be hided with black lines to prevent any exposure of identity.

All tables must be included in the manuscript file, should start on separate pages and be accompanied by a title, and footnotes where necessary. The tables should be numbered consecutively using Arabic numerals. Units in which results are expressed should be given in parentheses at the top of each column and not repeated in each line of the table.

Informed Consent and Ethics

Manuscript repoting the results of experimental investigations on human subjects must include a statement in the Materials and Methods section that the institutional review board has approved the study and the informed consent were obtained from patient or parents. The author(s) should state the accordance to the Declaration of Helsinki. Also, the experimental studies must be approved by the ethics commitee for animal use and proper ethics.

Correspondence

Heart and Health Foundation of Turkey

Address: Şair Eşref Bulvarı, 1402 Sk. No. 2/2 Özbaş Apt. Alsancak – İZMİR / TÜRKİYE
Phone: +90 232 464 19 63
Fax: +90 232 464 24 70
E-mail: info@.......org